Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT05678894 |
Other study ID # |
2022-A01313-40 |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
February 1, 2023 |
Est. completion date |
February 1, 2027 |
Study information
Verified date |
December 2022 |
Source |
GCS Ramsay Santé pour l'Enseignement et la Recherche |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The main objective is to show that the upper acetabular anteversions calculated in standing,
sitting, sitting hip in maximum flexion and supine positions are lower in patients with
symptomatic DWI compared to healthy volunteers.
Description:
The study will be presented to a population of symptomatic DWI patients who are offered hip
arthroscopy. As these measurements have never been performed before in a control population,
the study will also be proposed to a population of healthy volunteers, matched by age, sex,
BMI and level of sports activity, in order to have comparative reference values.
The study consisted of cross-sectional imaging and 3D reconstruction to measure and compare
acetabular anteversion in 4 functional pelvic positions in both groups.
- Group 1: Symptomatic DWI patients
- Group 2: Healthy volunteers
For symptomatic patients, the preoperative workup will be the same as in routine practice and
will include an X-ray as well as a CT scan. Low-dose EOS imaging of the pelvis in profile in
3 positions (standing sagittal tilt, sitting, maximum hip flexion) will complete this workup
in the context of the study, to know the sacral slope associated with each of these
positions. If the preoperative workup does not include a CT or arthroscan scan with
measurement of femoral anteversion, it will be requested in the low-dose protocol.
The control group will perform a CT scan and EOS imaging in the same 3 positions as the
patient group.
From the CT scan, a 3D reconstruction with the BoneMetrix software to calculate the superior
acetabular anteversion plane will be performed, giving the anteversion for a supine patient.
The software also allows to modify the orientation of the pelvis, according to the results of
the sacral slope obtained from the EOS assessment for the calculation of the superior
acetabular anteversion in the 3 requested positions. Finally, this 3D reconstruction will
allow us to search for the impingement dynamically after pelvis-femur segmentation and to
measure the position (degree of femoral flexion) in which it occurs.
As these measurements have never been performed before, a control population is needed to
obtain reference values for acetabular behavior that does not lead to symptomatic CFA. This
population will be matched by age, sex, BMI and sports activity to the study population.
The results obtained from the 2 populations will be compared. For the operated DWI patients
in the cohort, the clinical scores will be evaluated at 6 months and 2 years postoperatively
to search for a correlation between these scores and the superior acetabular version angles
obtained.
This monocentric study will take place at the Clinique de la Sauvegarde. Patients will be
seen in consultation by Dr Bonin or Dr Guicherd. They will be included during the
pre-operative consultation during which they will be presented with the examinations to be
performed, as well as the study. Their consent will be sought before any preliminary
procedure. Imaging will be performed at the Clinique du Parc, as is already done for these
patients, outside of any study.